Rekvina Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Rekvina Laboratories Ltd. on BSE

Search Inside the pdf :

Rekvina Laboratories Ltd.

21 Feb 2025

SAST

REKVINA LABORATORIES LTD. - 526075 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilsan Pharma Impex Pvt Ltd

pdf

Rekvina Laboratories Ltd.

18 Feb 2025

SAST

REKVINA LABORATORIES LTD. - 526075 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Abhijit Dharmeshbhai Mehta

pdf

Rekvina Laboratories Ltd.

30 Jan 2025

Corp. Note

REKVINA LABORATORIES LTD. - 526075 - Integrated Filing (Financial)

BSE India

Integrated Financial Result for quarter and nine months ended on 31st December 2024

pdf

Rekvina Laboratories Ltd.

20 Jan 2025

Result

REKVINA LABORATORIES LTD. - 526075 - Quarter And Nine Months Ended On 31St December 2024.

BSE India

Financial Result for Quarter and Nine Months Ended On 31st December 2024.

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	0.00	0.00	0.00	-	-
Operating Profit Qtr	-0.02	-0.07	-0.00	71.4%	-
Net Profit Qtr	-0.02	-0.07	-0.00	71.4%	-
Earning Per Share Adjusted latest Qtr	-0.04	-0.11	-0.01	63.6%	-300.0%

* Standalone data

Detailed Results

Rekvina Laboratories Ltd.

20 Jan 2025

Board Meeting

REKVINA LABORATORIES LTD. - 526075 - Board Meeting Outcome for Board Meeting Outcome For Board Meeting …

BSE India

Pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 20th January, 2025 has inter-alia adopted and approved 1)The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2024. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2024.

pdf

Rekvina Laboratories Ltd.

20 Jan 2025

Company Update

REKVINA LABORATORIES LTD. - 526075 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

pdf

Rekvina Laboratories Ltd.

13 Jan 2025

Board Meeting

REKVINA LABORATORIES LTD. - 526075 - Board Meeting Intimation for Board Meeting To Be Held On …

BSE India

REKVINA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on 20th January, 2025, inter alia; 1. To consider and approve Un-audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter ended on 31st December, 2024. 2. Any other agendas as may be considered necessary with the permission of the chair.

pdf